Legend Biotech (LEGN) Total Liabilities (2019 - 2025)

Legend Biotech (LEGN) has 7 years of Total Liabilities data on file, last reported at $731.6 million in Q4 2025.

• In Q4 2025, Total Liabilities rose 16.2% year-over-year to $731.6 million; the TTM figure through Dec 2025 stood at $731.6 million (up 16.2% YoY), while the FY2025 annual figure was $731.6 million, up 16.2% from the prior year.
• Total Liabilities grew to $731.6 million in Q4 2025, from $701.7 million in the prior quarter.
• Across five years, Total Liabilities topped out at $408.8 billion in Q1 2021 and bottomed at $535206.0 in Q2 2021.
• A 5-year average of $23.2 billion and a median of $599.9 million in 2022 frame the typical range for Total Liabilities.
• The widest YoY moves for Total Liabilities: up 184.36% in 2021, down 100.0% in 2021.
• Year by year, Total Liabilities stood at $353.5 million in 2021, then jumped by 65.95% to $586.7 million in 2022, then rose by 1.8% to $597.2 million in 2023, then increased by 5.42% to $629.6 million in 2024, then rose by 16.2% to $731.6 million in 2025.
• The last three Total Liabilities figures came in at $731.6 million (Q4 2025), $701.7 million (Q3 2025), and $654.4 million (Q2 2025), per Business Quant data.

Peer Comparison